Burden and costs of migraine in a Swedish defined patient population – a questionnaire-based study

Abstract Background Migraine is a disabling, chronic neurological disease leading to severe headache episodes affecting 13.2% of the Swedish population. Migraine leads to an extensive socio-economic burden in terms of healthcare costs, reduced workforce and quality of life (QoL) but studies of the h...

Full description

Bibliographic Details
Main Authors: Frida Hjalte, Sara Olofsson, Ulf Persson, Mattias Linde
Format: Article
Language:English
Published: BMC 2019-05-01
Series:The Journal of Headache and Pain
Subjects:
Online Access:http://link.springer.com/article/10.1186/s10194-019-1015-y
_version_ 1819133780751810560
author Frida Hjalte
Sara Olofsson
Ulf Persson
Mattias Linde
author_facet Frida Hjalte
Sara Olofsson
Ulf Persson
Mattias Linde
author_sort Frida Hjalte
collection DOAJ
description Abstract Background Migraine is a disabling, chronic neurological disease leading to severe headache episodes affecting 13.2% of the Swedish population. Migraine leads to an extensive socio-economic burden in terms of healthcare costs, reduced workforce and quality of life (QoL) but studies of the health-economic consequences in a Swedish context are lacking. The objective of this study is to map the health-economic consequences of migraine in a defined patient population in terms of healthcare consumption, production loss and QoL in Sweden. Methods The study is based on data from a web-based survey to members in the Swedish patients’ association suffering from migraine. The survey was conducted in May 2018 and included people with migraine aged 18 years or older. The survey included questions on health resource consumption, lost production resulting from migraine-related absenteeism and presenteeism, and QoL as measured by the EuroQol 5 dimensions questionnaire (EQ-5D-5 L) and the Headache Impact Test (HIT-6). The results are presented in yearly costs per patient and losses in quality adjusted life years (QALYs). Results The results are based on answers from 630 individuals with migraine and are presented by number of migraine days per month. The total cost per patient and year increased with the number of migraine days per month (p < 0.001) and varied between approximately €5000 for those with less than 3 migraine days per month and €24,000 per year for those with 21–28 migraine days per month. Production loss represented the main part of the costs, approximately 80%. The average loss in QALYs per year also increased with the monthly number of migraine days (p = 0.023). Conclusions Migraine leads to significant societal costs and loss of quality of life. There appears to be an unmet need and a potential for both cost savings and QoL benefits connected with a reduction in the number of migraine days.
first_indexed 2024-12-22T09:52:44Z
format Article
id doaj.art-1afde265881c4d6a8f86b69868f36138
institution Directory Open Access Journal
issn 1129-2369
1129-2377
language English
last_indexed 2024-12-22T09:52:44Z
publishDate 2019-05-01
publisher BMC
record_format Article
series The Journal of Headache and Pain
spelling doaj.art-1afde265881c4d6a8f86b69868f361382022-12-21T18:30:21ZengBMCThe Journal of Headache and Pain1129-23691129-23772019-05-012011910.1186/s10194-019-1015-yBurden and costs of migraine in a Swedish defined patient population – a questionnaire-based studyFrida Hjalte0Sara Olofsson1Ulf Persson2Mattias Linde3The Swedish Institute for Health Economics (IHE)The Swedish Institute for Health Economics (IHE)The Swedish Institute for Health Economics (IHE)Department of Neuromedicine and Movement Sciences, NTNU Norwegian University of Science and TechnologyAbstract Background Migraine is a disabling, chronic neurological disease leading to severe headache episodes affecting 13.2% of the Swedish population. Migraine leads to an extensive socio-economic burden in terms of healthcare costs, reduced workforce and quality of life (QoL) but studies of the health-economic consequences in a Swedish context are lacking. The objective of this study is to map the health-economic consequences of migraine in a defined patient population in terms of healthcare consumption, production loss and QoL in Sweden. Methods The study is based on data from a web-based survey to members in the Swedish patients’ association suffering from migraine. The survey was conducted in May 2018 and included people with migraine aged 18 years or older. The survey included questions on health resource consumption, lost production resulting from migraine-related absenteeism and presenteeism, and QoL as measured by the EuroQol 5 dimensions questionnaire (EQ-5D-5 L) and the Headache Impact Test (HIT-6). The results are presented in yearly costs per patient and losses in quality adjusted life years (QALYs). Results The results are based on answers from 630 individuals with migraine and are presented by number of migraine days per month. The total cost per patient and year increased with the number of migraine days per month (p < 0.001) and varied between approximately €5000 for those with less than 3 migraine days per month and €24,000 per year for those with 21–28 migraine days per month. Production loss represented the main part of the costs, approximately 80%. The average loss in QALYs per year also increased with the monthly number of migraine days (p = 0.023). Conclusions Migraine leads to significant societal costs and loss of quality of life. There appears to be an unmet need and a potential for both cost savings and QoL benefits connected with a reduction in the number of migraine days.http://link.springer.com/article/10.1186/s10194-019-1015-yMigraineCostWork productivityQuality of lifeEQ-5DSweden
spellingShingle Frida Hjalte
Sara Olofsson
Ulf Persson
Mattias Linde
Burden and costs of migraine in a Swedish defined patient population – a questionnaire-based study
The Journal of Headache and Pain
Migraine
Cost
Work productivity
Quality of life
EQ-5D
Sweden
title Burden and costs of migraine in a Swedish defined patient population – a questionnaire-based study
title_full Burden and costs of migraine in a Swedish defined patient population – a questionnaire-based study
title_fullStr Burden and costs of migraine in a Swedish defined patient population – a questionnaire-based study
title_full_unstemmed Burden and costs of migraine in a Swedish defined patient population – a questionnaire-based study
title_short Burden and costs of migraine in a Swedish defined patient population – a questionnaire-based study
title_sort burden and costs of migraine in a swedish defined patient population a questionnaire based study
topic Migraine
Cost
Work productivity
Quality of life
EQ-5D
Sweden
url http://link.springer.com/article/10.1186/s10194-019-1015-y
work_keys_str_mv AT fridahjalte burdenandcostsofmigraineinaswedishdefinedpatientpopulationaquestionnairebasedstudy
AT saraolofsson burdenandcostsofmigraineinaswedishdefinedpatientpopulationaquestionnairebasedstudy
AT ulfpersson burdenandcostsofmigraineinaswedishdefinedpatientpopulationaquestionnairebasedstudy
AT mattiaslinde burdenandcostsofmigraineinaswedishdefinedpatientpopulationaquestionnairebasedstudy